List of content:
Background
Mission Statement
Aims and Functions
Structure and Membership
Officers of CUC
Founding Members
List of Officers
BackgroundFollowing the “Sino-European Conference on TCM” held in Rome in June 2007, hosted by the Italian Ministry of Health with the Chinese Ministry of Science & Technology, and the EU Commission, the urgency for the establishment of a UK Consortium to co-ordinate medical integration, research and collaborations with China became apparent. Chinese Medicine in the UK is amongst the most developed within the European Community with well established centres of excellence in clinical practice for nearly four decades and a mature consumer acceptance of Chinese medicine treatment. Numerous academic institutions and research centres in the UK are now engaged in projects of research and integration connected with Chinese medicine, pharmacology and R&D programmes in collaboration with the Chinese counterparts. As these different areas of medical integration, research and collaboration, projects are gathering momentum with the increasing economic and cultural impact of China, the formation of the China-UK Consortium (CUC) is timely and necessary. The CUC will ensure a unified voice to represent the UK in these fields on the international platform, especially with the EU and China. The CUC will also provide a focal point for exchange and collaboration between members to enhance the effectiveness of partner projects, to avoid duplication and waste of resources. In China and EU, funds are now available for the international community earmarked for Chinese medicine development and medical integration. The CUC will enhance the UK possibility of obtaining a reasonable portion of these funds for development projects within the UK. International co-operation, especially with our European partners, will be made more creditable through the office of the CUC. The current climax of global medical integration necessitates attention from the UK government, academic institutions and corporate enterprises towards this historical opportunity. This is precisely the background in which the CUC is formed.
back to top
Mission Statement| 1) | The CUC strives to represent a united voice for collaboration with China to promote medical integration and integrative healthcare East and West. | | 2) | To ensure effective use of available resources, the CUC provides support of its member organisations in the pursuit of optimal qualitative attainment. | | 3) | To represent the UK in the participation of international events, exchange and partnership in the relevant fields of its remit. |
back to top
Aims and Functions| 1) | The general aim of the CUC is to facilitate the research and development of Chinese medicine, as well as integration with mainstream medicine by promoting exchange and collaboration with China. | | 2) | The general function of the CUC is to provide a platform of convergence and a united body of representation for its members in the pursuit of their projects in terms of international recognition and funding. | | 3) | The boundaries of remit of the consortium include high quality academic research, education, clinical practice, and corporate research & development projects as defined by the following specific areas: | | | a) | To participate in the modernisation of TCM and its integration with mainstream medicine; | | b) | To promote the globalisation of Chinese medicine as a part of the international integration in medicine and healthcare; | | c) | To co-ordinate and initiate projects of collaboration within the CUC remit; | | d) | To support the exchange of information and experimental data on the advances in medical integration; | | e) | To establish academic programmes of education and research in the UK and China on designated topics of mutual interest; | | f) | To seek and develop business opportunity for collaboration with a view to income generation; | | g) | To represent the UK in international events, liaison and business within its remit; | | h) | To collectively seek funding for projects within the CUC memberships; | | i) | To develop strategy that enhances appraisal and performance. |
|
back to top
Structure and MembershipThe structure of the CUC is based on a federated model. Membership consists of organisations (represented by authorised personnel of that organisation) that subscribe to the mission statement, aims and functions of the CUC. | By initiating the formation of the CUC, founding members agree on the criteria and categories of memberships as follow: | | 1) | Founding members are automatically being included in the Steering Board of the consortium, responsible for the strategy and leadership of the consortium. | | 2) | | Criteria for approval of full consortium membership are: | | a) | Active engagement in the development of the CUC, commit to promoting and enhancing good practice; | | b) | Participation in the activities of the consortium; | | c) | Of good reputation and influence in the respective fields within the CUC remit; | | d) | Contribute positively to promote the aims and functions of the CUC | | e) | Non-profit organizations | | f) | Overseas organisations |
| | 3) | The procedure for membership approval is by voting within the Steering Board on the basis of a simple majority; | | 4) | | Full membership categories are: | | a) | Academic & Research Membership | | b) | Clinical Organisation Membership | | c) | Corporate Enterprise Membership | | d) | Non-profit organizations |
| | 5) | The CUC content of this founding document on the structure, and the membership of the CUC will be reviewed as needed. |
|
back to top
Officers of the CUCBy election at the founding meeting on the 18th August 2007 for an initial term of 3 years, but not limited to 3 years. | a) | 1 Chair of Steering Board | | b) | 3 Vice chairs of the Steering Board responsible for Projects, Education and Training, and Strategy Development | | c) | Executive Members of the Steering Board | | d) | Treasurer of the CUC | | e) | Secretary of the CUC | | f) | Advisory board (to be established) | | | - | Legal adviser | | - | Financial adviser | | - | Political adviser (UK) | | - | Political adviser (China) | | - | Corporate affairs adviser | | - | Academic adviser | | - | Organisational governance adviser | | - | Consumer - Lay adviser | | - | EU relation adviser |
|
The individual members of the Steering Board cannot take decisions which would jeopardise CUC’s financial status. back to top
Founding MemberDeclared at the Formation Meeting on 18th August 2007 | Member | Institution | Head of Projects | | | | | | Chinese Academic Collaboration Programme | Chinese Medical Institute and Register (CMIR) | Prof. Man Fong Mei | Pharmaceutical & Natural Products Research Group, Department of Pharmacy, School of Applied Sciences | University of Wolverhampton | Prof. Kelvin Chan | Centre for Clinical Excellence | AcuMedic Foundation | Prof. Man Fong Mei | Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy | University of London | Prof. Michael Heinrich | Institute for Health Research and Policy (IHRP) | London Metropolitan University | Professor Christopher Branford-White | School of Pharmacy | University of Reading | Prof. Elizabeth Williamson
Dr Yuling Ma | Section of Molecular Therapeutics and Ovarian Cancer Action (HHMT) Research Unit | Imperial College London | Prof. Hani Gabra
Prof. Steven Lin | Pharmaceutical R&D Subsidiary | Mei Group Plc | Prof. Man Fong Mei | UKCGCM | UKCGCM | Prof. Kenneth Muir
as representative | Centre for Complementary Healthcare and Integrated Medicine (CCHIM) | Thames Valley University | Prof. Nicola Robinson | Nottingham UK-China Collaboration on Complementary & Alternative Medicine (NUCCAM) | Nottingham University | Prof. Kenneth Muir
Dr. Jin Xu | School of Biomedical and Health Sciences | King's College, London | Prof Robert Hider
Prof. Peter Hylands | Angiogenesis & TCM Laboratory
Department of Pharmacology | University of Cambridge | Dr. Tai-Ping Fan | Brunel Institute for Bioengineering | Brunel University | Prof. Ian A.Sutherland
Prof. Derek Fisher | Institute of Pharmaceutical Innovation | University of Bradford | Dr. Qun Shao |
back to top
List of OfficersElected at Founding Meeting on 18th August 2007
Chair of Steering Board
Prof. Man Fong Mei
Vice chairs of the Steering Board
Prof. Kelvin Chan - Projects
Prof. Christopher Branford-White - Strategic Development
Prof. Kenneth Muir - Academic and Research
Executive Members of the Steering Board
Prof. Michael Heinrich - Quality Assurance
Prof. Steven Lin - Product Development
Prof. Elizabeth Williamson - TCM and Healthcare
Prof. Nicola Robinson - NHS Liaison
Prof. Ian A. Sutherland – Public Relation
Dr. Tai-Ping Fan – Research Coordinator
Prof. Peter Hylands – Pharmaceutical Analysis
Treasurer of the CUC
Dr. Johnny Hon
Secretary of the CUC
Sherry Zhang
European Consultant
Dr. Wang Ning
Corporate affairs adviser
Christopher Bielenberg
back to top
© China-UK Consortium for Medical Integration, Research and Collaboration 2007-2008
|
